Shaad Essa Abedin MD FACP (He/Him)
Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology
Physician
Join to view full profile
405 Chatham Heights RdFredericksburg, VA 22405
Phone+1 540-300-6182
Fax+1 646-349-7620
Dr. Abedin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Physician scientist and healthcare consultant with 10+ year experience in exploratory research and clinical drug development. Dr. Abedin is a practicing physician who is board certified in internal medicine, hematology and medical oncology, with a diverse skill set of preclinical lab based experience, Phase 1 to 3 Trial design, strategy, global execution and approvals.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2009 - 2012
University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2006 - 2009
Dow University of Health SciencesClass of 2004
Certifications & Licensure
DC State Medical License 2013 - 2028
MD State Medical License 2012 - 2028
VA State Medical License 2012 - 2026
FL State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow American College of Physicians, 2015
- CMS Meaningful Use Stage 1 Certification IMS, MedPharm Services LLC, 2014-2015
- CMS Meaningful Use Stage 1 Certification Intelligent Medical Software (IMS), SuiteMed, 2014-2015
Publications & Presentations
PubMed
- 3 citationsRadiomic markers associated with clinical benefit in patients with radiographic progression of advanced uveal melanoma on tebentafusp.Volkan Beylergil, Laura Collins, Lawrence H Schwartz, Thomas Eche, Binsheng Zhao
European Journal of Cancer. 2025-05-02 - 15 citationsTebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of Action.Jessica C Hassel, Sarah Stanhope, Alexander Greenshields-Watson, Devayani Machiraju, Alexander Enk
The Journal of Investigative Dermatology. 2025-03-01 - Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development.Tao Wang, Shaad Essa Abedin, Jan Willem van der Laan
Frontiers in Oncology. 2025-01-01
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- Hindi, Punjabi, Urdu
External Links
- Websitehttp://www.fda.gov/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: